Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Biosimilar of Remicade Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Biosimilar of Remicade Industry
  • 1.7 COVID-19 Impact: Biosimilar of Remicade Market Trends

    • 2 Global Biosimilar of Remicade Quarterly Market Size Analysis

    • 2.1 Biosimilar of Remicade Business Impact Assessment - COVID-19
      • 2.1.1 Global Biosimilar of Remicade Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Biosimilar of Remicade Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Biosimilar of Remicade Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Biosimilar of Remicade Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Biosimilar of Remicade Market
    • 3.4 Key Players Biosimilar of Remicade Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Biosimilar of Remicade Segments, By Type

    • 4.1 Introduction
      • 1.4.1 100mg/10ml
      • 1.4.2 500mg/50ml
    • 4.2 By Type, Global Biosimilar of Remicade Market Size, 2019-2021

    5 Impact of Covid-19 on Biosimilar of Remicade Segments, By Application

    • 5.1 Overview
      • 5.5.1 Blood Disorders
      • 5.5.2 Oncology Diseases
    • 5.2 By Application, Global Biosimilar of Remicade Market Size, 2019-2021
      • 5.2.1 By Application, Global Biosimilar of Remicade Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Synthon Pharmaceuticals
      • 7.1.1 Synthon Pharmaceuticals Business Overview
      • 7.1.2 Synthon Pharmaceuticals Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.1.3 Synthon Pharmaceuticals Biosimilar of Remicade Product Introduction
      • 7.1.4 Synthon Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.2 LG Life Sciences
      • 7.2.1 LG Life Sciences Business Overview
      • 7.2.2 LG Life Sciences Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.2.3 LG Life Sciences Biosimilar of Remicade Product Introduction
      • 7.2.4 LG Life Sciences Response to COVID-19 and Related Developments
    • 7.3 Novartis (Sandoz)
      • 7.3.1 Novartis (Sandoz) Business Overview
      • 7.3.2 Novartis (Sandoz) Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.3.3 Novartis (Sandoz) Biosimilar of Remicade Product Introduction
      • 7.3.4 Novartis (Sandoz) Response to COVID-19 and Related Developments
    • 7.4 Celltrion
      • 7.4.1 Celltrion Business Overview
      • 7.4.2 Celltrion Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.4.3 Celltrion Biosimilar of Remicade Product Introduction
      • 7.4.4 Celltrion Response to COVID-19 and Related Developments
    • 7.5 Biocon
      • 7.5.1 Biocon Business Overview
      • 7.5.2 Biocon Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.5.3 Biocon Biosimilar of Remicade Product Introduction
      • 7.5.4 Biocon Response to COVID-19 and Related Developments
    • 7.6 Hospira
      • 7.6.1 Hospira Business Overview
      • 7.6.2 Hospira Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.6.3 Hospira Biosimilar of Remicade Product Introduction
      • 7.6.4 Hospira Response to COVID-19 and Related Developments
    • 7.7 Merck Serono (Merck Group)
      • 7.7.1 Merck Serono (Merck Group) Business Overview
      • 7.7.2 Merck Serono (Merck Group) Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.7.3 Merck Serono (Merck Group) Biosimilar of Remicade Product Introduction
      • 7.7.4 Merck Serono (Merck Group) Response to COVID-19 and Related Developments
    • 7.8 Biogen idec Inc.
      • 7.8.1 Biogen idec Inc. Business Overview
      • 7.8.2 Biogen idec Inc. Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.8.3 Biogen idec Inc. Biosimilar of Remicade Product Introduction
      • 7.8.4 Biogen idec Inc. Response to COVID-19 and Related Developments
    • 7.9 Genentech (Roche Group)
      • 7.9.1 Genentech (Roche Group) Business Overview
      • 7.9.2 Genentech (Roche Group) Biosimilar of Remicade Quarterly Revenue, 2020
      • 7.9.3 Genentech (Roche Group) Biosimilar of Remicade Product Introduction
      • 7.9.4 Genentech (Roche Group) Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Biosimilar of Remicade, including the following market information:
      Global Biosimilar of Remicade Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biosimilar of Remicade Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biosimilar of Remicade Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Biosimilar of Remicade Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc., Genentech (Roche Group), etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      100mg/10ml
      500mg/50ml

      Based on the Application:
      Blood Disorders
      Oncology Diseases

      Buy now